Diagnostics & Clinical Services
Clinical laboratories; clinical trial sites; imaging services; pathology and specialized testing.
NTM Growth %
to
EV / NTM Rev (x)
to
Mkt Cap ($B)
to
Showing 7 of 7 companies
| Company | Mkt Cap ↓ | EV | EV / LTM Rev | EV / NTM Rev | EV / LTM EBITDA | EV / NTM EBITDA | NTM Growth | Gross Margin | EBITDA Margin | FCF Margin | Rule of 40 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | 3.4x | 2.6x | 21.5x | 13.9x | 22.7% | 33.1% | 7.9% | 4.0% | 23.0% | |||
| Mean | 8.0x | 5.8x | 121.1x | 14.5x | 24.1% | 43.0% | 1.9% | -2.8% | 21.3% | |||
| NTRANatera, Inc. | $39.36B | $38.51B | 16.7x | 12.4x | — | — | 35.0% | 65.2% | -8.9% | 4.0% | 39.0% | |
| DGXQuest Diagnostics Incorporated | $25.83B | $31.58B | 2.9x | 2.6x | 14.4x | 12.1x | 11.9% | 33.1% | 17.4% | 11.1% | 22.9% | |
| LHLabcorp Holdings Inc. | $25.54B | $32.17B | 2.3x | 2.1x | 16.0x | 12.6x | 8.7% | 27.8% | 15.0% | 8.3% | 17.0% | |
| GHGuardant Health, Inc. | $21.43B | $22.04B | 22.4x | 13.7x | — | — | 64.1% | 65.0% | -34.8% | -24.5% | 39.6% | |
| EXASExact Sciences Corporation | $20.03B | $21.58B | 6.6x | 5.4x | 426.9x | 18.1x | 22.7% | 69.7% | 1.7% | 11.0% | 33.7% | |
| RDNTRadNet, Inc. | $5.41B | $6.89B | 3.4x | 2.6x | 27.1x | 15.1x | 30.2% | 9.4% | 15.1% | -7.3% | 23.0% | |
| OPKOPKO Health, Inc. | $970M | $1.06B | 1.7x | 1.8x | — | — | -4.2% | 31.0% | 7.9% | -22.1% | -26.3% |